Table 2 Postoperative cardiopulmonary complications
β2-agonists group (n = 71) | Control group (n = 103) | P-value | |
|---|---|---|---|
Cardiovascular complications | 7 (10%) | 10 (10%) | 0.974 |
Atrial arrhythmias | 7 (10%) | 8 (8%) | 0.629 |
Atrial fibrillation | 7 (10%) | 7 (7%) | 0.465 |
Paroxysmal supraventricular tachycardia | 0 | 1 (1%) | 0.405 |
Acute myocardial infarction | 0 | 1 (1%) | 0.405 |
Thromboembolic events | 0 | 2 (2%) | 0.238 |
Respiratory complications | 9 (13%) | 11 (11%) | 0.685 |
Pneumonia | 5 (7%) | 5 (5%) | 0.542 |
Atelectasis with bronchoscopic therapy | 4 (6%) | 4 (4%) | 0.588 |
Respiratory insufficiency requiring tracheostomy | 0 | 1 (1%) | 0.405 |
Respiratory failure requiring mechanical ventilation | 1 (1%) | 3 (3%) | 0.515 |